These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 6418548)
61. Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders. Figgitt DP; McClellan KJ Drugs; 2000 Oct; 60(4):925-54. PubMed ID: 11085201 [TBL] [Abstract][Full Text] [Related]
62. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Sánchez C; Hyttel J Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421 [TBL] [Abstract][Full Text] [Related]
65. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Preskorn SH Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931 [TBL] [Abstract][Full Text] [Related]
66. Overview of the pharmacokinetics of fluvoxamine. van Harten J Clin Pharmacokinet; 1995; 29 Suppl 1():1-9. PubMed ID: 8846617 [TBL] [Abstract][Full Text] [Related]
68. Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humans. Skene DJ; Bojkowski CJ; Arendt J Br J Clin Pharmacol; 1994 Feb; 37(2):181-6. PubMed ID: 8186063 [TBL] [Abstract][Full Text] [Related]
70. Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness. Wilde MI; Plosker GL; Benfield P Drugs; 1993 Nov; 46(5):895-924. PubMed ID: 7507038 [TBL] [Abstract][Full Text] [Related]
71. Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Benfield P; Ward A Drugs; 1986 Oct; 32(4):313-34. PubMed ID: 3096686 [TBL] [Abstract][Full Text] [Related]
72. Excretion of fluvoxamine in breast milk. Wright S; Dawling S; Ashford JJ Br J Clin Pharmacol; 1991 Feb; 31(2):209. PubMed ID: 1904751 [No Abstract] [Full Text] [Related]
73. Screening and identification of sumatriptan and its main metabolite by means of thin-layer chromatography, ultraviolet spectroscopy and gas chromatography/mass spectrometry. Rochholz G; Ahrens B; König F; Schütz HW; Schütz H; Seno H Arzneimittelforschung; 1995 Sep; 45(9):941-6. PubMed ID: 7488309 [TBL] [Abstract][Full Text] [Related]
74. Identification of metabolism pathways of anticancer drugs by high-pressure liquid chromatography in combination with field desorption mass spectrometry. Przybylski M Arzneimittelforschung; 1982; 32(9):995-1012. PubMed ID: 6756419 [TBL] [Abstract][Full Text] [Related]
75. Fluvoxamine maleate: metabolism in man. Overmars H; Scherpenisse PM; Post LC Eur J Drug Metab Pharmacokinet; 1983; 8(3):269-80. PubMed ID: 6418548 [TBL] [Abstract][Full Text] [Related]
76. Fluvoxamine: metabolic fate in animals. Ruijten HM; de Bree H; Borst AJ; de Lange N; Scherpenisse PM; Vincent WR; Post LC Drug Metab Dispos; 1984; 12(1):82-92. PubMed ID: 6141918 [TBL] [Abstract][Full Text] [Related]
77. Review of the animal pharmacology and pharmacokinetics of fluvoxamine. Claassen V Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):349S-355S. PubMed ID: 6407497 [TBL] [Abstract][Full Text] [Related]